Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, you can change weight loss injections — switching from one GLP-1 medicine to another, or adjusting your dose, is clinically possible and sometimes the right move. What it is not is something you should do alone. Every change to a prescription-only medicine requires a prescriber to review your case first, weigh up your current progress, and decide the safest path forward. This page explains how that process works in practice, what drives the decision, and what to expect on the other side of a switch.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people ask about switching for one of three reasons. Side effects on their current injection are making treatment hard to sustain. Progress has stalled despite reaching a higher dose. Or they have heard that a different medicine produces better results and want to know whether the evidence supports a move.
All three are legitimate clinical questions. Mounjaro activates two gut-hormone receptors simultaneously (GIP and GLP-1), while Wegovy targets the GLP-1 receptor alone. In the SURMOUNT-5 trial, published in the New England Journal of Medicine, tirzepatide produced greater average weight reduction than semaglutide 2.4mg over 72 weeks in adults with obesity who did not have diabetes. That does not automatically make it the right choice for every individual, your prescriber looks at the whole picture, not just a headline figure.
Equally, some people find the GI side-effect profile of one medicine easier to tolerate than the other. Nausea, reflux and constipation vary between patients and between medicines. A prescriber who knows your history can assess whether a switch is likely to help or simply swap one set of challenges for another. For a thorough overview of what these medicines involve before any decision, the information on weight loss injections page covers the clinical background in full.
This step sounds obvious. In practice, people sometimes stop one injection and start another without a clinical review in between, particularly if they are ordering from different providers. That is a risk worth understanding.
Both Mounjaro and Wegovy slow gastric emptying and reduce appetite through overlapping mechanisms. Starting a second GLP-1 medicine too quickly after stopping the first can intensify side effects, and dosing schedules do not simply transfer across medicines. A 5mg Mounjaro dose does not correspond to a specific Wegovy dose; they are different molecules on different dose ladders, and the prescriber decides where to start the new medicine based on your individual situation, not a conversion table.
There is also the question of how long you can be on weight loss injections, something a prescriber looking at a switch will often consider alongside the change itself, making it a separate but related clinical question that sits naturally in the same conversation. If you are thinking about that question in more depth, our page on how long you can realistically use weight loss injections explores the evidence and clinical thinking behind treatment duration.
The NHS England guidance on weight management injections makes clear that these medicines are prescribed within a broader framework of clinical support, the medicine is one component, not the whole plan.
At nume, every repeat order and every request to change treatment goes to a real clinician, a GPhC-registered Independent Prescriber reads your case, not software. That matters when the question is as nuanced as switching between two prescription medicines mid-treatment.
The review covers your current dose, how long you have been on it, what your weight trajectory looks like, and whether side effects or lack of progress are genuinely the driver behind the request. Transfer patients are asked to provide evidence of their existing treatment before any change is made. That is not bureaucracy, it is the only way to make a safe decision. You can see how our clinical team approaches these decisions on the clinical team profile page.
Once a switch is agreed, treatment is dispatched the same day for orders placed before noon, it arrives the next working day via tracked DPD delivery, in plain packaging. If you have questions before or after, aftercare is available seven days a week. For anyone weighing up whether a change is right for them, a useful first read is our page on eligibility and suitability for weight loss injections, which covers the licensed criteria in full.
Sometimes the right answer after a clinical review is not to switch but to pause or stop treatment. That is a separate decision with its own considerations, including whether and how weight is maintained afterwards. Our page on stopping weight loss injections covers that process honestly, what typically happens to appetite and weight, what the evidence suggests about long-term management, and when a pause is likely to be temporary versus the end of a treatment course.
One thing that does not change regardless of the decision: these are prescription-only medicines, and the right place to make any change is in a consultation with a prescriber who knows your case. If you are currently on treatment through a different provider and thinking about moving, or if you have been on the same medicine for a while and want a clinical view on whether a switch makes sense, a free consultation at our treatment page is the practical next step. You can also explore the broader weight loss treatment options available, and if you have concerns about safety, our page addressing whether weight loss injections can kill you sets out the evidence clearly, to understand the landscape before you decide.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.